SUNESIS PHARMACEUTICALS INC's ticker is and the CUSIP is 867328951. A total of 2 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $1,534,000 | +22.8% | 5,097 | 0.0% | 0.06% | +7.7% |
Q1 2015 | $1,249,000 | +92.2% | 5,097 | +460.1% | 0.05% | +108.0% |
Q3 2014 | $650,000 | -13.6% | 910 | -21.1% | 0.02% | -21.9% |
Q2 2014 | $752,000 | +39.0% | 1,153 | +41.0% | 0.03% | +6.7% |
Q1 2014 | $541,000 | +50.3% | 818 | +7.6% | 0.03% | +30.4% |
Q4 2013 | $360,000 | -65.5% | 760 | -62.0% | 0.02% | -67.1% |
Q2 2013 | $1,042,000 | – | 2,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 5,097 | $1,534,000 | 0.06% |
GROUP ONE TRADING, L.P. | 40,100 | $121,000 | 0.00% |
Citadel Advisors | 18,600 | $56,000 | 0.00% |